查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2028 年的流感疫苗市場預測——COVID-19 的影響以及按疫苗類型、病毒類型、技術、給藥途徑和目標群體進行的全球分析
市場調查報告書
商品編碼
1153721

到 2028 年的流感疫苗市場預測——COVID-19 的影響以及按疫苗類型、病毒類型、技術、給藥途徑和目標群體進行的全球分析

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group
出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 訂單完成後即時交付

價格

流感疫苗市場預計將從 2021 年的 747853 萬美元增長到 2028 年的 1227249 萬美元。預計從 2022 年到 2028 年，複合年增長率將達到 7.4%。政府加大對促進流感疫苗接種的支持以及市場領先公司和政府加大投資是推動市場的主要因素。

州政府支持促進疫苗接種計劃的努力。例如，澳大利亞政府通過其國家免疫計劃 (NIP) 向面臨流感相關並發症風險的人群免費分發季節性流感疫苗。到 2022 年，將有足夠的疫苗覆蓋所有有資格通過 NIP 獲得政府資助的流感疫苗的風險人群。

以下是一些支持政府支持流感疫苗接種的例子。

2022 年 7 月，公共服務和採購部長 Filomena Tassi 和衛生部長 Jean-Yves Duclos 宣布，加拿大政府將與GlaxoSmithCry (GSK) 簽署一份新合同，以支持可持續的流感大流行準備工作。加拿大政府維持大流行性流感疫苗儲備，以防流感大流行。

2022 年 7 月，衛生部長 Audrey Gordon 和長期護理部長 Scott Johnston 宣布，高劑量流感疫苗將擴大到所有 65 歲及以上的成年人，以幫助保護更多曼尼托巴居民免受流感侵害。

維多利亞州政府已收到一項撥款和報銷計劃，以在 2022 年 6 月和 2022 年 7 月之前改善全科醫生和藥房對流感疫苗的獲取和使用。

2022 年 6 月，新西蘭政府從 2022 年 7 月 1 日起將免費流感疫苗的使用範圍擴大到另外 800,000 名新西蘭人。現在可以為 3 至 12 歲的兒童以及有嚴重心理健康和成癮問題的人免費接種流感疫苗。

台灣疾病預防控制中心（台灣CDC）和衛生福利部舉行了題為“讓我們一起保持健康”的媒體活動，啟動了 2021 年政府資助的流感疫苗接種計劃。活動現場，周局長、譚大使、蔣新率先接種流感疫苗，並呼籲符合政府資助流感疫苗接種條件的人員在項目結束後儘快接種流感疫苗。

2019 年 9 月，美國總統唐納德特朗普簽署了一項行政命令，促進開發更好的疫苗，以防止季節性和潛在的大流行性流感爆發。

2021 年 10 月，隨著流感季節的臨近，州政府敦促所有紐芬蘭人和拉布拉多人接種流感疫苗。從 2021 年 10 月 25 日起，地方衛生局 (RHA) 開始提供免費的流感疫苗接種診所。此外，人們可以通過家庭醫生或當地藥房接種疫苗。因此，越來越多的政府支持在全球範圍內推廣流感疫苗接種，推動了流感疫苗市場的發展。

疫苗類型見解

根據疫苗類型，流感疫苗市場分為四價和三價疫苗。預計四價疫苗部分將在 2022 年佔據更大的市場份額。該細分市場預計在預測期內將實現高複合年增長率。四價流感疫苗可預防四種流感病毒，包括兩種甲型流感病毒和兩種乙型流感病毒。美國 2021-2022 季的所有流感疫苗均為四價疫苗。不同的疫苗被批准用於不同的年齡組。

病毒類型洞察

根據病毒類型，流感疫苗市場分為甲型流感病毒和乙型流感病毒。預計該細分市場在預測期內將實現更快的複合年增長率。A 型流感病毒的市場增長是由於它是最常見的流感形式，可以感染動物，儘管與這種流感相關的疾病更為常見。

技術見解

基於技術，流感疫苗市場分為蛋基和細胞基。到 2022 年，以雞蛋為基礎的細分市場預計將佔據更大的市場份額。預計該細分市場在預測期內將實現更快的複合年增長率。以雞蛋為基礎的細分市場的市場增長歸功於通過使用了 70 多年的以雞蛋為基礎的製造工藝來製造流感疫苗的最常見方法。

給藥途徑洞察力

根據給藥途徑，流感疫苗市場分為註射劑和鼻腔噴霧劑。注射劑預計將在 2022 年佔據更大的市場份額。預計該細分市場在預測期內將實現更高的複合年增長率。可注射部分的市場增長歸因於它是最常見的流感疫苗接種方法。

目標群體見解

全球流感疫苗市場按目標群體分為嬰兒、兒童、成人和老年人。到 2021 年，嬰兒細分市場將佔據更大的市場份額。然而，在預測期內，老年人（老年人）部分預計將以最高增長率增長。

報告中引用了國際貿易管理局 (ITA)、Farmindustria-Bain & Company、EFPIA 成員協會、世界衛生組織 (WHO)、國際商業監測 (BMI)、急診醫學部、Indian Journal of Medical Sciences等流感疫苗市場。是一些主要和次要信息

目錄

第 1 章 簡介

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球流感疫苗市場，按疫苗類型
    • 按病毒類型劃分的全球流感疫苗市場
    • 全球流感疫苗市場，按技術分類
    • 全球流感疫苗市場:按給藥途徑分類
    • 全球流感疫苗市場:按目標組
    • 全球流感疫苗市場，按地區

第二章流感疫苗市場——要點

第三章研究方法論

  • 調查對象
  • 二次調查
  • 初步調查

第四章流感疫苗市場——市場格局

  • PEST分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太 PEST 分析
    • 中東和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 專家意見

5 全球流感疫苗市場——主要市場動態

  • 市場驅動力
    • 加大政府對推廣流感疫苗的支持力度
    • 頂級公司和政府增加投資
  • 市場製約因素
    • 疫苗研發成本高
  • 市場機會
    • 新興市場的發展
  • 未來趨勢
    • 強大的流感疫苗候選管道
  • 影響分析

第六章流感疫苗市場——全球分析

  • 全球流感疫苗市場:收入和預測與分析
  • 全球流感疫苗市場:按地區預測和分析
  • 全球流感疫苗市場:區域市場潛力分析
  • 公司分析
    • 主要參與者的市場定位
    • 公司比較分析
  • 增長戰略分析
  • 主要參與者的表現
    • Sanofi
    • Sekiras

第 7 章流感疫苗市場分析和預測到 2028 年（按疫苗類型）

  • 全球流感疫苗市場:2022-2028 (%) by Vaccine Type
  • 四價疫苗
  • 三價疫苗

第 8 章流感疫苗市場分析和預測到 2028 年（按病毒類型）

  • 全球流感疫苗市場:2022 年和 2028 年 (%) 按病毒類型
  • A型流感病毒
  • B型流感病毒

到 2028 年的第 9 章流感疫苗市場分析和預測（按技術）

  • 2022 年和 2028 年按技術分列的全球流感疫苗市場 (%)
  • 雞蛋為主
  • 基於細胞的

第 10 章流感疫苗市場分析及到 2028 年的預測（按給藥途徑）

  • 全球流感疫苗市場:2022 年和 2028 年（%）按給藥途徑
  • 注射
  • 噴鼻劑

第 11 章流感疫苗市場分析和預測到 2028 年（按目標組）

  • 全球流感疫苗市場:2022-2028 年按目標組劃分（%）
  • 嬰兒
  • 孩子
  • 成人
  • 老年人

第 12 章流感疫苗市場分析和預測到 2028 年（區域分析）

    • 北美
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
      • 日本
      • 中國
      • 韓國
      • 澳大利亞
      • 亞太其他地區
    • 中東/非洲
      • 沙特阿拉伯
      • 阿聯酋
      • 南非
      • 其他中東
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 其他拉丁美洲地區

第 13 章 COVID-19 大流行對全球流感疫苗市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第 14 章流感疫苗市場:行業格局

  • 2021-2028 年流感疫苗市場增長戰略
  • 無機增長戰略
  • 有機增長戰略

第十五章公司簡介

  • Moderna, Inc.
  • SEQIRUS
  • Sanofi
  • GlaxoSmithKline plc.
  • Hualan Biological Engineering Inc.
  • Emergent BioSolutions Inc.
  • Mitsubishi Chemical Group Corporation
  • Serum Institute of India Pvt. Ltd
  • MYLAN N.V.
  • AstraZeneca

第十六章 附錄

  • 關於洞察合作夥伴
  • 詞彙表
Product Code: TIPRE00004070

The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a CAGR of 7.4% from 2022 to 2028. Increasing government support to promote influenza vaccination and rising investment by top market players and governments are the major factors boosting the market.

The governments of various states are supporting the promotional activities of vaccination program. For instance, the Australian government gives a free seasonal influenza vaccine to those at risk of influenza-related complications through the National Immunization Program (NIP). By 2022, enough vaccines have been given to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination:

In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic.

In July 2022, Health Minister Audrey Gordon and Long-term Care Minister Scott Johnston announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure more Manitoba people are protected against influenza.

The Victorian government received a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022.

In June 2022, The New Zealand government expanded the access to free flu vaccines, with an additional 800,000 New Zealanders eligible from July 1, 2022. Children aged 3 to 12 years and people with severe mental health or addiction problems can now get a free dose of the flu vaccines.

Taiwan's Centers for Disease Control (Taiwan CDC), and the Ministry of Health and Welfare, organized a media event, titled "Let's Stay Healthy Together" to kick off the 2021 government-funded influenza vaccination program. At the event, Director General Chou, Ambassador Tan, and Hsin Chiang were the first to be vaccinated to encourage eligible people to receive government-funded flu vaccines to get their flu vaccinations as soon as possible following the program.

In September 2019, US President Donald Trump signed an executive order to promote the development of better vaccines to protect against seasonal flu and the potential for pandemic flu outbreaks.

In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination worldwide is driving the influenza vaccines market.

Vaccine Type Insights

Based on the vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment is likely to hold a larger market share in 2022. The same segment is anticipated to register a higher CAGR during the forecast period. The quadrivalent influenza (flu) vaccine protects against 4 influenza viruses, including 2 influenza A viruses and 2 influenza B viruses. All flu vaccines in the US during the 2021-2022 season are quadrivalent vaccines. Different vaccines are approved for different age groups.

Virus Type Insights

Based on virus type, the influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the influenza virus type A segment is because it is the most common form of influenza and can infect animals, although illnesses associated with this type of flu are more common.

Technology Insights

Based on technology, the influenza vaccines market is segmented into egg-based and cell-based. The egg-based segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the egg-based segment is due to its most common method of producing flu vaccines through an egg-based manufacturing process that has been used for more than 70 years.

Route of Administration Insights

Based on route of administration, the influenza vaccines market is segmented into injection and nasal spray. The injection segment is likely to hold a larger market share in 2022. The same segment is expected to register a higher CAGR during the forecast period. The market growth of the injection segment is attributed to the fact that it is the most common method for flu vaccine administration.

Target Group Insights

Based on target group, the global influenza vaccines market is divided into infants, children, adults, and elderly people. The infants segment held larger share of the market in 2021. However, the elderly (geriatric population) segment is expected to grow at the highest growth rate during the forecast period.

International Trade Administration (ITA), Farmindustria-Bain & Company, EFPIA member associations, World Health Organization (WHO), Business Monitor International (BMI), Department of Emergency Medicine, and Indian Journal of Medical Sciences are among the primary and secondary sources referred to while preparing the report on the influenza vaccines market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the influenza vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Influenza Vaccines Market - By Vaccine Type
    • 1.3.2 Global Influenza Vaccines Market - By Virus Type
    • 1.3.3 Global Influenza Vaccines Market - By Technology
    • 1.3.4 Global Influenza Vaccines Market - By Route of Administration
    • 1.3.5 Global Influenza Vaccines Market - By Target Group
    • 1.3.6 Global Influenza Vaccines Market - By Geography

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Influenza Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. Global Influenza Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Government Support to Promote Influenza Vaccination
    • 5.1.2 Increasing Investment by Top Market Players and Governments
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Vaccine Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
  • 5.5 Impact Analysis

6. Influenza Vaccine Market -Global Analysis

  • 6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis
  • 6.2 Global Influenza Vaccines Market, By Geography - Forecasts And Analysis
  • 6.3 Global Influenza Vaccines Market - Market Potential Analysis, By Region
  • 6.4 Company Analysis
    • 6.4.1 Market Positioning of Key Players
    • 6.4.2 Comparative Company Analysis
  • 6.5 Growth Strategy Analysis
  • 6.6 Performance of Key Players
    • 6.6.1 Sanofi
    • 6.6.2 SEQIRUS

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

  • 7.1 Overview
  • 7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Overview
    • 7.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Trivalent Vaccines
    • 7.4.1 Overview
    • 7.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

  • 8.1 Overview
  • 8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
  • 8.3 Influenza Virus Type A
    • 8.3.1 Overview
    • 8.3.2 Influenza Virus Type A Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Influenza Virus Type B
    • 8.4.1 Overview
    • 8.4.2 Influenza Virus Type B Market Revenue and Forecast to 2028 (US$ Mn)

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

  • 9.1 Overview
  • 9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)
  • 9.3 Egg-based
    • 9.3.1 Overview
    • 9.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Cell-based
    • 9.4.1 Overview
    • 9.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

  • 10.1 Overview
  • 10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
  • 10.3 Injection
    • 10.3.1 Overview
    • 10.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Nasal Spray
    • 10.4.1 Overview
    • 10.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

  • 11.1 Overview
  • 11.2 Global Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
  • 11.3 Infants
    • 11.3.1 Overview
    • 11.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Children
    • 11.4.1 Overview
    • 11.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Adults
    • 11.5.1 Overview
    • 11.5.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Elderly People
    • 11.6.1 Overview
    • 11.6.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

  • 12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
    • 12.1.1 Overview
    • 12.1.2 North America: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.1.3 North America: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    • 12.1.4 North America: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    • 12.1.5 North America: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    • 12.1.6 North America: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    • 12.1.7 North America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.1.8 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.1.8.1 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.1.1 Overview
        • 12.1.8.1.2 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.1.4 US: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.1.5 US: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.1.7 US: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.8.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.2.1 Overview
        • 12.1.8.2.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.2.5 Canada: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.8.3 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.3.1 Overview
        • 12.1.8.3.2 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.2 Europe: Influenza Vaccines Market
    • 12.2.1 Overview
    • 12.2.2 Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.3 Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    • 12.2.4 Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    • 12.2.5 Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    • 12.2.6 Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    • 12.2.7 Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.2.8 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.2.8.1 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.1.1 Overview
        • 12.2.8.1.2 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.1.5 Germany: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.2.1 Overview
        • 12.2.8.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.2.5 UK: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.2.7 UK: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.3 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.3.1 Overview
        • 12.2.8.3.2 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.3.4 France: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.3.5 France: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.3.7 France: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.4 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.4.1 Overview
        • 12.2.8.4.2 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.4.5 Italy: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.5 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.5.1 Overview
        • 12.2.8.5.2 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.5.5 Spain: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.6 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.6.1 Overview
        • 12.2.8.6.2 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.3 Asia Pacific: Influenza Vaccines Market
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    • 12.3.3 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    • 12.3.4 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    • 12.3.5 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    • 12.3.6 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    • 12.3.7 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.3.8 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.3.8.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.1.1 Overview
        • 12.3.8.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.2.1 Overview
        • 12.3.8.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.2.7 China: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.3.1 Overview
        • 12.3.8.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.3.7 India: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.4.1 Overview
        • 12.3.8.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.5.1 Overview
        • 12.3.8.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.6 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.3.8.6.1 Overview
        • 12.3.8.6.2 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.3.8.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.4 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.4.1 Overview
    • 12.4.2 Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.4.3 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    • 12.4.4 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    • 12.4.5 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    • 12.4.6 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    • 12.4.7 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.4.8 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.4.8.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.4.8.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.4.8.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.5 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    • 12.5.3 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    • 12.5.4 South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    • 12.5.5 South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    • 12.5.6 South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    • 12.5.7 South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.5.8 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.5.8.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.1.1 Overview
        • 12.5.8.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.5.8.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.2.1 Overview
        • 12.5.8.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.5.8.3 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.3.1 Overview
        • 12.5.8.3.2 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

  • 13.1 North America: Impact Assessment of COVID-19 Pandemic
  • 13.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Influenza Vaccine Market -Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
  • 14.3 Inorganic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Organic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Moderna, Inc.
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 SEQIRUS
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Sanofi
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 GlaxoSmithKline plc.
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Hualan Biological Engineering Inc.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Emergent BioSolutions Inc.
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Mitsubishi Chemical Group Corporation
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Serum Institute of India Pvt. Ltd
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 MYLAN N.V.
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 AstraZeneca
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. North America Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 4. North America Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 5. North America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 11. Canada Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 16. Mexico Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Mexico Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 21. Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Europe Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 26. Germany Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Germany Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Germany Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 31. UK Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. UK: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. UK Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. UK Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. UK Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 36. France Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. France: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. France Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. France Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. France Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 41. Italy Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Italy: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Italy Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Italy Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Italy Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 46. Spain Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Spain: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Spain Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Spain Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Spain Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 51. Rest of Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Europe Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 56. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
  • Table 57. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 58. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 59. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
  • Table 60. Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 61. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 62. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 63. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 64. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 65. Japan Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 66. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 67. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 68. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 69. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 70. China Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 71. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 72. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 73. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 74. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 75. India Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 76. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 77. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 78. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 79. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 80. South Korea Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 81. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 82. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 83. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 84. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 85. Australia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 86. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 87. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 88. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 89. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 90. Rest of Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 91. Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 92. Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 93. Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 94. Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 95. Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 96. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
  • Table 98. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 99. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 100. Saudi Arabia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 101. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 102. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 103. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 104. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 105. UAE Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 106. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 107. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 108. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 109. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 110. South Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 111. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 112. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 113. Rest of Middle East & Africa Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 114. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 115. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 116. South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 117. South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 118. South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 119. South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 120. South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 121. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 122. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 123. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 124. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 125. Brazil Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 126. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 127. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 128. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 129. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 130. Argentina Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 131. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 132. Rest of South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 133. Rest of South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 134. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 135. Rest of South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 136. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
  • Table 137. Recent Organic Growth Strategies in the Influenza Vaccine Market
  • Table 138. Glossary of Terms, Influenza Vaccines Market

List Of Figures

  • Figure 1. Influenza Vaccines Market Segmentation
  • Figure 2. Influenza Vaccines Market Segmentation, by Region
  • Figure 3. Global Influenza Vaccines Market Overview
  • Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Influenza Vaccines Market
  • Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Influenza Vaccines Market, By Geography (USD Million)
  • Figure 7. Global Influenza Vaccines Market- Leading Country Markets (USD Million)
  • Figure 8. Global Influenza Vaccines Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Global Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
  • Figure 16. Global Influenza Vaccines Market - By Geography Forecasts and Analysis - 2022- 2028
  • Figure 17. Global Influenza Vaccines Market - Market Potential Analysis, By Region
  • Figure 18. Market Positioning of Key Players In Global Influenza Vaccines Market
  • Figure 19. Global Influenza Vaccines Market - Comparative Company Analysis
  • Figure 20. Global Influenza Vaccines Market - Growth Strategy Analysis
  • Figure 21. Global Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
  • Figure 22. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. Global Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
  • Figure 25. Powder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. Tablets Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 27. Global Influenza Vaccines Market, by Technology 2022 & 2028 (%)
  • Figure 28. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Global Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
  • Figure 31. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 33. Global Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
  • Figure 34. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. North America: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 41. US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 45. Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 47. Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
  • Figure 54. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 56. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 58. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 60. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 61. Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 63. Middle East & Africa Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
  • Figure 64. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 65. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 66. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 67. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 68. Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 69. South and Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
  • Figure 70. South and Central America Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
  • Figure 71. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 72. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 73. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. Impact of COVID-19 Pandemic on North America Countries
  • Figure 76. Impact of COVID-19 Pandemic on European Countries
  • Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries
  • Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 80. Growth Strategies in the Influenza Vaccine Market, 2021-2028